The invite was announced at the end of a hearing last week on the impact of high drug costs on patients.
“I want to tell you, this may make you feel some hope: We’re going to have the drug company folks sitting in the same seats as soon as we come back,” Mr. Cummings said, according to The Hill. “And we’re going to try to understand some of why they’re doing what they’re doing.”
The House Oversight panel launched an investigation into high drug costs and demanded documents from drugmakers in January, but pharmaceutical executives have not testified before the committee.
Drug company executives were grilled by the Senate Finance Committee earlier this year. Most of the executives blamed insurers and pharmacy benefit managers for high drug prices.
More articles on pharmacy:
9 recent drug, device recalls
Owens Healthcare to sell 12 retail pharmacies to CVS
The pharmacies that received the most opioids in every state
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
